Capital Research Global Investors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472M | Sell |
|
|||||
|
2025
Q1 | $822M | Sell |
|
|||||
|
2024
Q4 | $1.12B | Sell |
|
|||||
|
2024
Q3 | $1.2B | Buy |
|
|||||
|
2024
Q2 | $1.35B | Sell |
|
|||||
|
2024
Q1 | $1.86B | Sell |
|
|||||
|
2023
Q4 | $1.9B | Buy |
|
|||||
|
2023
Q3 | $1.18B | Buy |
|
|||||
|
2023
Q2 | $1.17B | Sell |
|
|||||
|
2023
Q1 | $1.08B | Sell |
|
|||||
|
2022
Q4 | $1.07B | Sell |
|
|||||
|
2022
Q3 | $848M | Buy |
|
|||||
|
2022
Q2 | $573M | Sell |
|
|||||
|
2022
Q1 | $1.35B | Buy |
|
|||||
|
2021
Q4 | $1.28B | Buy |
|
|||||
|
2021
Q3 | $836M | Buy |
|
|||||
|
2021
Q2 | $611M | Buy |
|
|||||
|
2021
Q1 | $142M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $51.5M | Buy |
|